Baotou INST Magnetic New Materials
301622
HEATKING
838670
Qingdao Guolin Technology Group
300786
Efort Intelligent Equipment Co., Ltd.
688165
Tianjin Ruixin Technology
300828
CN Stock MarketDetailed Quotes
300109 Boai NKY Medical
- 17.75
- +2.96+20.01%
Market Closed Dec 4 15:00 CST
8.60BMarket Cap21.54P/E (TTM)
17.75High14.55Low844.91KlotVolume14.62Open14.79Pre Close1.43BTurnover18.85%Turnover Ratio17.45P/E (Static)484.70MShares17.7552wk High2.45P/B7.96BFloat Cap7.3552wk Low17.75Limit Up448.34MShs Float59.97Historical High11.83Limit Down21.64%Amplitude1.44Historical Low0.67Dividend TTM16.98Avg Price433.14KlotAsk3.76%Div YieldTTM100Lot Size371.37KlotBid
Boai NKY Medical News
Boai Nky Medical (300109.SZ): The company currently has an aggregate capacity of 0.034 million tons of nvp and 0.02 million tons of pvp.
On November 28, Gelonghui reported that boai nky medical (300109.SZ) indicated on the investor interaction platform that the company currently has an aggregate capacity of 0.034 million tons of NVP and 0.02 million tons of PVP. In the future, based on market sales and the expansion of product applications, the company will timely adjust the NVP monomer capacity and PVP aggregation capabilities.
Boai nky medical (300109.SZ): The company's products can be used in solid state batteries.
According to Boai Nky Medical (300109.SZ) on the investor interaction platform, the company's products can be used in solid state batteries.
Boai NKY Medical Holdings' (SZSE:300109) Shareholders Have More To Worry About Than Only Soft Earnings
New Open Source: 2024 Q3 Report
Boai Nky Medical (300109.SZ) released its performance for the first three quarters, with a net income of 0.311 billion yuan, a year-on-year decrease of 23.13%.
Boai nky medical (300109.SZ) disclosed the third quarter report of 2024, with the company achieving revenue of 11....
Boai Nky Medical (300109.SZ): The net income in the third quarter was 98.3134 million yuan, a 31.11% year-on-year decrease.
On October 22, Geelong released its third quarter report for 2024. In the third quarter of 2024, the company achieved revenue of 0.376 billion yuan, a decrease of 12.00% year-on-year; net income attributable to the company's shareholders was 98.3134 million yuan, a decrease of 31.11% year-on-year; net income after excluding non-recurring gains and losses was 0.104 billion yuan, a decrease of 27.73% year-on-year; basic earnings per share were 0.20 yuan per share.
Boai NKY Medical Holdings Ltd.'s (SZSE:300109) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Boai Nky Medical (300109.SZ): Executives Zou Xiaowen and Li Shegang plan to reduce their holdings by a total of no more than 0.2495 million shares.
Boai NKY Medical (300109.SZ) announced on September 18th that Mr. Zou Xiaowen, a senior management personnel, held 667,904 shares of the company's stock as of the announcement date, accounting for 0.14% of the total share capital of the company. Mr. Zou plans to reduce his shareholding of the company by no more than 166,976 shares (not exceeding 0.03% of the total share capital) through centralized bidding or block trading within 3 months after 15 trading days from the date of the announcement (from October 17, 2024 to January 16, 2025, excluding the blackout period). He currently holds 330,000 shares of the company's stock, accounting for
New open source: 2024 semi-annual report
New Open Source: 2024 Semi-Annual Report Summary
Boai Nky Medical (300109.SZ): The net income in the first half of the year was 0.213 billion yuan, a year-on-year decrease of 18.79%.
On August 29th, boai nky medical (300109.SZ) released its interim report for the first half of 2024. During the reporting period, the total operating revenue was RMB 0.735 billion, a decrease of 5.68% year-on-year. The net income attributable to shareholders of the listed company was RMB 0.213 billion, a decrease of 18.79% year-on-year. After deducting non-recurring gains and losses, the net income attributable to shareholders of the listed company was RMB 0.218 billion, a decrease of 15.36% year-on-year. The basic earnings per share were RMB 0.45.
Boai Nky Medical (300109.SZ) released its semi-annual performance, with a net income of 0.213 billion yuan, a decrease of 18.79%.
boai nky medical (300109.SZ) released its 2024 interim report, with revenue of 0.735 billion yuan...
We Think Boai NKY Medical Holdings (SZSE:300109) Can Stay On Top Of Its Debt
As of August 9th, the number of shareholders for Boai Nky Medical (300109.SZ) was approximately 23,700 when combined.
Boai Nky Medical (300109.SZ) stated on the investor interaction platform on August 13th that the number of shareholders of the company as of August 9th was about 23,700 after merging.
As of the end of July, the shareholder count of Boai Nky Medical (300109.SZ) is approximately 22,800 households.
Boai Nky Medical (300109.SZ) stated on the investors' interactive platform on August 6th that as of the end of July, the number of shareholders of the company was about 22,800.
Earnings Growth of 36% Over 1 Year Hasn't Been Enough to Translate Into Positive Returns for Boai NKY Medical Holdings (SZSE:300109) Shareholders
As of July 20, the number of shareholders of Boai Nky Medical (300109.SZ) was approximately 22,700.
On July 24, Gelunhui reported that as of July 20, the number of shareholders in Boai Nky Medical (300109.SZ) was approximately 22,700.
As of July 10th, the number of shareholders of Boai Nky Medical (300109.SZ) has merged to about 23,100.
On July 16th, Gelunhui reported that as of July 10th, the total number of shareholders of Boai Nky Medical (300109.SZ) was around 23,100 on the investor interaction platform.
Boai Nky Medical (300109.SZ): Sales of vinyl ether products are relatively low and are still being developed in the market.
On July 8th, Gelunhui reported that an investor asked a question on the investor interaction platform to Boai Nky Medical (300109.SZ) about the progress of ethylene ether products in 2023, besides PVP and Eurazeo. The company replied that the sales volume of ethylene ether products is small and is still being developed in the market.
Boai Nky Medical (300109.SZ): The annualized production capacity of PVP is about 20,000 tons.
On July 3rd, Gelonhui reported that Boai Nky Medical (Stock Code: 300109) stated on the investor interaction platform that the annual production capacity of PVP is about 20,000 tons, and the specific capacity can be adjusted in a timely manner according to sales.
